Q-1.

How should Biopharma have used its production network in 2013? Should any of the plants have been idled? What is the annual cost of your proposal, including import duties?

Q-2.

How should Landgraf structure his global production network? Assume that the past is a reasonable indicator of the future in terms of exchange rates.

Q-3.

Is there any plant for which it may be worth adding a million kilograms of additional capacity at a fixed cost of $3 million per year?

Q-4.

How are your recommendations affected by the reduction of duties?

Q-5.

The analysis has assumed that each plant has a 100 percent yield (percentage output of acceptable quality). How would you modify your analysis to account for yield differences across plants?

Q-6.

What other factors should be accounted for when making your recommendations?